Blood cancer treatment options expand in Duluth
Local hospitals are bringing FDA-approved Bispecific T-cell Engager therapy to the region. Providers claim it could extend and improve blood cancer patients' quality of life.
University Of Minnesota United States Mayo Clinic In Rochester Robert Erickson Homam Alkaied Lainee Gatzlaff
Source: duluthnewstribune.com